Thermodynamic Analyses of Fuel Production Via Solar-Driven Ceria-Based Nonstoichiometric Redox Cycling: A Case Study of the Isothermal Membrane Reactor System

A thermodynamic model of an isothermal ceria-based membrane reactor system is developed for fuel production via solar-driven simultaneous reduction and oxidation reactions. Inert sweep gas is applied on the reduction side of the membrane. The model is based on conservation of mass, species, and energy along with the Gibbs criterion. The maximum thermodynamic solar-to-fuel efficiencies are determined by simultaneous multivariable optimization of operational parameters. The effects of gas heat recovery and reactor flow configurations are investigated. The results show that maximum efficiencies of 1.3% (3.2%) and 0.73% (2.0%) are attainable for water splitting (carbon dioxide splitting) under counter- and parallel-flow configurations, respectively, at an operating temperature of 1900 K and 95% gas heat recovery effectiveness. In addition, insights on potential efficiency improvement for the membrane reactor system are further suggested. The efficiencies reported are found to be much lower than those reported in literature. We demonstrate that the thermodynamic models reported elsewhere can violate the Gibbs criterion and, as a result, lead to unrealistically high efficiencies. The present work offers enhanced understanding of the counter-flow membrane reactor and provides more accurate upper efficiency limits for membrane reactor systems. © 2019 by ASME.Australian Research Council (Wojciech Lipiński, Future Fellowship, Award No. FT140101213, Funder ID. 10.13039/501100000923). China Scholarship Council (Sha Li, Grant No. [2015] 3022, 201506020092, Funder ID. 10.13039/501100004543)

Peri-exercise co-ingestion of branched-chain amino acids and carbohydrate in men does not preferentially augment resistance exercise-induced increases in PI3K/Akt-mTOR pathway markers indicative of muscle protein synthesis

The effects of a single bout of resistance exercise (RE) in conjunction with peri-exercise branched chain amino acid (BCAA) and carbohydrate (CHO) ingestion on skeletal muscle signaling markers indicative of muscle protein synthesis (MPS) were determined. It was hypothesized that CHO + BCAA would elicit a more profound effect on these signaling markers compared to CHO. Twenty-seven males were randomly assigned to CHO, CHO + BCAA, or placebo (PLC) groups. Four sets of leg presses and leg extensions were performed at 80% 1RM. Supplements were ingested 30 min and immediately prior to and after RE. Venous blood and muscle biopsy samples were obtained immediately prior to supplement ingestion and 0.5 hr, 2 hr, and 6 hr after RE. Serum insulin and glucose and phosphorylated levels of muscle insulin receptor substrate 1 (IRS1), protein kinase B (Akt), mammalian target of rapamycin (mTOR), p70S6 kinase (p70S6K), and 4E binding protein 1 (4E-BP1) were assessed. Data were analyzed by two-way repeated measures ANOVA. Significant group x time interactions were observed for glucose and insulin (p \u3c 0.05) showing that CHO and CHO + BCAA were significantly greater than PLC. Significant time main effects were observed for IRS1 (p = 0.001), Akt (p = 0.031), mTOR (p = 0.003), and p70S6K (p = 0.001). CHO and CHO + BCAA supplementation significantly increased IRS-1 compared to PLC (p = 0.002). However, peri-exercise co-ingestion of CHO and BCAA did not augment RE-induced increases in skeletal muscle signaling markers indicative of MPS when compared to CHO

International Society of Sports Nutrition position stand: beta-alanine

Position statement: The International Society of Sports Nutrition (ISSN) provides an objective and critical review of the mechanisms and use of beta-alanine supplementation. Based on the current available literature, the conclusions of the ISSN are as follows: 1) Four weeks of beta-alanine supplementation (4–6 g daily) significantly augments muscle carnosine concentrations, thereby acting as an intracellular pH buffer; 2) Beta-alanine supplementation currently appears to be safe in healthy populations at recommended doses; 3) The only reported side effect is paraesthesia (tingling), but studies indicate this can be attenuated by using divided lower doses (1.6 g) or using a sustained-release formula; 4) Daily supplementation with 4 to 6 g of beta-alanine for at least 2 to 4 weeks has been shown to improve exercise performance, with more pronounced effects in open end-point tasks/time trials lasting 1 to 4 min in duration; 5) Beta-alanine attenuates neuromuscular fatigue, particularly in older subjects, and preliminary evidence indicates that beta-alanine may improve tactical performance; 6) Combining beta-alanine with other single or multi-ingredient supplements may be advantageous when supplementation of beta-alanine is high enough (4–6 g daily) and long enough (minimum 4 weeks); 7) More research is needed to determine the effects of beta-alanine on strength, endurance performance beyond 25 min in duration, and other health-related benefits associated with carnosine

Modeling and Simulation of Coating Growth on Nanofibers

This work presents modeling and simulation results of a procedure to coat nanofibers and core-clad nanostructures with thin film materials using plasma enhanced physical vapor deposition. In the experimental effort that motivates the modeling, electrospun polymer nanofibers are coated with metallic materials under different operating conditions to observe changes in the coating morphology. The modeling effort focuses on linking simple models at the reactor, nanofiber, and atomic levels to form a comprehensive model. Numerical simulations that link the concentration field with the evolution of the coating free surface predict that as the Damkohler number is increased the coating morphology changes from a wavy to a nodular to a dendritic needle-type form as observed experimentally

Effects of ingesting protein with various forms of carbohydrate following resistance-exercise on substrate availability and markers of anabolism, catabolism, and immunity

<p>Abstract</p> <p>Background</p> <p>Ingestion of carbohydrate (CHO) and protein (PRO) following intense exercise has been reported to increase insulin levels, optimize glycogen resynthesis, enhance PRO synthesis, and lessen the immuno-suppressive effects of intense exercise. Since different forms of CHO have varying glycemic effects, the purpose of this study was to determine whether the type of CHO ingested with PRO following resistance-exercise affects blood glucose availability and insulin levels, markers of anabolism and catabolism, and/or general immune markers.</p> <p>Methods</p> <p>40 resistance-trained subjects performed a standardized resistance training workout and then ingested in a double blind and randomized manner 40 g of whey PRO with 120 g of sucrose (S), honey powder (H), or maltodextrin (M). A non-supplemented control group (C) was also evaluated. Blood samples were collected prior to and following exercise as well as 30, 60, 90, and 120 min after ingestion of the supplements. Data were analyzed by repeated measures ANOVA or ANCOVA using baseline values as a covariate if necessary.</p> <p>Results</p> <p>Glucose concentration 30 min following ingestion showed the H group (7.12 ± 0.2 mmol/L) to be greater than S (5.53 ± 0.6 mmol/L; p < 0.03); M (6.02 ± 0.8 mmol/L; p < 0.05), and C (5.44 ± 0.18 mmol/L; p < 0.0002) groups. No significant differences were observed among groups in glucose area under the curve (AUC) values, although the H group showed a trend versus control (p = 0.06). Insulin response for each treatment was significant by time (p < 0.0001), treatment (p < 0.0001) and AUC (p < 0.0001). 30-min peak post-feeding insulin for S (136.2 ± 15.6 <it>u</it>IU/mL), H (150.1 ± 25.39 <it>u</it>IU/mL), and M (154.8 ± 18.9 <it>u</it>IU/mL) were greater than C (8.7 ± 2.9 <it>u</it>IU/mL) as was AUC with no significant differences observed among types of CHO. No significant group × time effects were observed among groups in testosterone, cortisol, the ratio of testosterone to cortisol, muscle and liver enzymes, or general markers of immunity.</p> <p>Conclusion</p> <p>CHO and PRO ingestion following exercise significantly influences glucose and insulin concentrations. Although some trends were observed suggesting that H maintained blood glucose levels to a better degree, no significant differences were observed among types of CHO ingested on insulin levels. These findings suggest that each of these forms of CHO can serve as effective sources of CHO to ingest with PRO in and attempt to promote post-exercise anabolic responses.</p

Co-ingestion of carbohydrate with branched-chain amino acids or L-leucine does not preferentially increase serum IGF-1 and expression of myogenic-related genes in response to a single bout of resistance exercise

This study determined if the co-ingestion of carbohydrate (CHO) with branched-chain amino acids (BCAA) or L-leucine (LEU) preferentially affected serum IGF-1 and the expression of myogenic-related genes in response to resistance exercise (RE). Forty one, college-age males were randomly assigned to 1 of 4 groups: CHO, CHO-BCAA, CHO-LEU, or placebo (PLC). Resistance exercise consisted of 4 sets of leg press and leg extension at 80% 1RM. Supplements were ingested peri-exercise, and venous blood and muscle biopsies were obtained pre-exercise (PRE), and at 30, 120, and 360 min post-exercise. Serum IGF-1 was determined with ELISA, and skeletal muscle mRNA expression of myostatin, ActRIIB, p21kip, p27kip, CDK2, cyclin B1, cyclin D1, Myo-D, myogenin, MRF-4, and myf5 was determined using real-time PCR. Results were determined with two-way ANOVA for serum IGF-1 and two-way MANOVA for mRNA expression. Serum IGF-1 in CHO and CHO+BCAA was greater than PLC (p \u3c 0.05) but was not affected by RE (p \u3e 0.05). Significant differences were detected between groups for myostatin, ActIIB, MyoD, and myf5 mRNA expression showing CHO to be significantly different than CHO+BCAA, CHO+LEU, and PLC (p \u3c 0.05). At 30, 120 and 360 min post-exercise, p21cip was significantly less than PRE, whereas cyclin D1 was greater than PRE at 120 and 360 min post-exercise (p \u3c 0.05). The co-ingestion of CHO with either BCAA or L-leucine in conjunction with RE had no preferential effect on serum IGF-1 or pre-translational markers indicative of myogenesis

Bioactive properties and clinical safety of a novel milk protein peptide

Milk protein fractions and peptides have been shown to have bioactive properties. This preliminary study examined the potential mechanisms of action and clinical safety of novel milk protein peptide (MP). A novel MP mixture inhibits the tyrosine kinase activity of epidermal growth factor receptor (EGFR), vascular endothelial growth factor receptor 2 (VEGFR2), and insulin receptor (IR) with IC50 of 9.85 μM, 7.7 μM, and 6.18 μM respectively. In vitro, this multi-kinase inhibitor causes apoptosis in HT-29 colon cancer cells, and in a C. elegans worm study, showed a weak but significant increase in lifespan. A six week double-blind, placebocontrolled study involving 73 healthy volunteers demonstrated that the MP mixture is safe to consume orally. All clinical blood markers remained within normal levels and no clinically significant side effects were reported. There was some evidence of improved insulin sensitivity, neutrophil-to-lymphocyte ratio (NLR), and quality of life assessment of role of physical function. These data in combination with the observed in vitro anti-cancer properties warrant further clinical studies to investigate this MP mixture as a potential clinical nutrition intervention for improving the quality of life and clinical outcomes in cancer patients